Skip to main content
Sisram Medical Ltd logo

Sisram Medical Ltd — Investor Relations & Filings

Ticker · 1696 ISIN · IL0011418113 HKEX Manufacturing
Open in API
Filings indexed 1,569 across all filing types
Latest filing 2023-08-11 Notice of Dividend Amou…
Country HK Hong Kong
Listing HKEX 1696

About Sisram Medical Ltd

http://www.sisram-medical.com

Sisram Medical Ltd. is a global consumer wellness group specializing in medical aesthetics and minimally invasive solutions. Leveraging over two decades of expertise, the company is a leader in Energy-Based Devices (EBD), harnessing natural energy sources for both aesthetic and medical clinical indications. Sisram operates through a synergistic ecosystem of brands, providing medical-grade quality solutions to professional customers and consumers worldwide. Key segments include Alma, a provider of energy-based solutions for surgical and medical aesthetics markets; LMNT, a personal care brand for home use; Copulla, which offers end-to-end digital dentistry services; and a dedicated injectables portfolio. The company's extensive product range covers treatments such as hair removal, skin rejuvenation, body contouring, and dermal fillers.

Recent filings

Filing Released Lang Actions
RECORD DATE AND WITHHOLDING TAX RATE IN CONNECTION WITH THE PAYMENT OF 2022 FINAL DIVIDEND
Notice of Dividend Amount Classification · 100% confidence The document is an announcement from Sisram Medical Ltd regarding the record date and withholding tax rate related to the payment of the 2022 final dividend. It references the dividend amount, payment date, shareholder eligibility, and tax withholding details. There is no detailed financial data, financial statements, or comprehensive report content. The document serves to inform shareholders about dividend payment logistics and tax implications rather than presenting a full dividend report or financial results. Therefore, it fits the category of a Notice of Dividend Amount, which covers announcements of dividend amounts, payment dates, and related shareholder information.
2023-08-11 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from the Board of Directors of Sisram Medical Ltd regarding the scheduling of a board meeting to consider and approve the interim results for the six months ended 30 June 2023 and the declaration of an interim dividend. The document does not contain the actual interim financial results or detailed financial data, but rather informs about the upcoming board meeting where these results will be reviewed. The document length is short (1408 characters) and it serves as a notice rather than a report. According to the classification rules, such announcements about the timing of board meetings to approve interim results are best classified as Regulatory Filings (RNS), since it is a general regulatory announcement and does not contain substantive financial data or the report itself.
2023-08-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2023
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 July 2023. It details movements in authorised/registered share capital, issued shares, convertibles, and confirms compliance with listing rules. It is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share issuance movements for a specific month. The document is not a financial report, earnings release, or management discussion, but a regulatory filing about share capital movements and confirmations. It is not an announcement of a report but the actual monthly return document. Therefore, the best fitting category is Regulatory Filings (RNS).
2023-08-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 July 2023. It details movements in authorised/registered share capital, issued shares, and confirms no changes in share options, warrants, convertibles, or other agreements to issue shares. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share issuance movements for the month. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to share capital movements. The document length is 4437 characters, which is relatively short and consistent with a regulatory filing rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-08-02 English
ANNUAL REPORT 2022/2023
Annual Report Classification · 100% confidence The document contains detailed sections typical of a comprehensive yearly corporate report, including Chairlady's Statement, Management Discussion and Analysis, Biographical Details of Directors and Senior Management, Report of the Directors, Corporate Governance Report, Environmental, Social and Governance Report, Independent Auditor's Report, and full consolidated financial statements with notes. The presence of a full set of financial statements and extensive narrative analysis for the fiscal year ended 31 March 2023 indicates this is a full Annual Report. The document length (15,000 characters) and content depth confirm it is not a brief announcement or a partial report. Therefore, the document is classified as an Annual Report (10-K equivalent). FY 2023
2023-07-28 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Sisram Medical Ltd regarding the launch of a new product, Alma Veil, in the U.S. market. It contains no financial data, no regulatory filing references, no voting results, no management changes, no financial results, and no detailed report content. The document is short (2299 characters) and serves as a product launch announcement rather than a financial or regulatory report. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is an announcement related to company business but not related to capital, management, or governance changes. Given the content and length, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2023-07-25 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.